Boston Biotech Conferences
BIOTECH - ERYTECH Pharma attends Boston Biotech Conferences on June 11 and 12 2013 at hotel Four Season, Boston, Massachussetts, USA.
View Article45th Société Française de Science et Techniques Pharmaceutiques Congress
SCIENTIFIC CONGRESS - ERYTECH Pharma attends 45th Société Française de Science et Techniques Pharmaceutiques Congress from June 12 to 13 2013 in Montpellier, France.
View Article18th European Hematology Association Congress
SCIENTIFIC CONGRESS - ERYTECH Pharma attends 18th European Hematology Association Congress which takes place from June 13 to 16 2013 in Stockholm, Sweden.
View ArticleERYTECH announces fast take-off of its Phase IIb study in Acute Myeloid Leukemia
ERYTECH announces fast take-off of its Phase IIb b study in Acute Myeloid Leukemia
View ArticleComptable Unique H/F
ERYTECH Pharma recherche un : Comptable Unique H/F Directement rattaché(e) au Responsable Administratif et Financier, sa principale mission sera de tenir la comptabilité de la société, élaborer les...
View ArticleRESPONSABLE DE PRODUCTION
ERYTECH Pharma recherche pour son Département Production un(e) RESPONSABLE DE PRODUCTION
View Article15th International Congress of Immunology
SCIENTIFIC CONGRESS - ERYTECH Pharma makes a presentation entitled Induction of immune tolerance by antigen loaded erythrocytes: Innovative therapy for therapeutic protein allergy at 15th International...
View ArticleOrphan Drugs summit 2013
SCIENTIFIC CONGRESS - ERYTECH Pharma participates in Orphan Drugs summit 2013 in Copenhagen, Denmark from September 11 to 13 2013.
View ArticleBioPharma America 2013
PARTNERING - ERYTECH Pharma takes part in 6th Annual International Partnering Conference BioPharm America 2013 from September 17-19 2013, in Boston, Ma, USA.
View ArticleERYTECH completes enrollment in its Phase III study in Acute Lymphoblastic...
ERYTECH completes enrollment in its Phase III study in Acute Lymphoblastic Leukemia
View ArticleERYTECH announces the granting of its core process patent in the United...
ERYTECH announces the granting of its core process patent in the United States with two additional years of exclusivity
View ArticleThe European Cancer Congress 2013
SCIENTIFIC CONGRESS - ERYTECH Pharma participates in The European Cancer Congress 2013 ECCO from September 27 to October 1, 2013, in Amsterdam, The Netherlands.
View Article13th Annual Biotech in Europe Investor Forum
FINANCE - ERYTECH Pharma attends 13th Annual Biotech in Europe Investor Forum on September 30 and October 1, 2013 in Zurich, Switzerland.
View ArticleERYTECH announces positive DSMB review of its Phase IIb study in Acute...
ERYTECH announces positive DSMB review of its Phase IIb study in Acute Myeloid Leukemia
View ArticleJefferies 2013 London Healthcare Conference
FINANCE - ERYTECH Pharma participates in Jefferies 2013 London Healthcare Conference which takes place at Waldorf Hilton, London (UK) on November 20-21, 2013.
View ArticleActionaria
FINANCE - ERYTECH Pharma participates in Actionaria, which takes place on November 22-23, 2013 at Palais des Congrès, Paris, France
View ArticleInternational GSD Conference 2013
ERYTECH Pharma takes part in International GSD Conference 2013 from November 28 to 30, 2013 in Heidelberg, Germany.
View ArticleERYTECH announces two presentations at 55th ASH annual meeting and exposition...
ERYTECH announces two presentations at 55th ASH annual meeting and exposition in New Orleans
View ArticleBref Rhône Alpes Innovation Award
ERYTECH Pharma wins the Bref Rhône Alpes Innovation Award in Health/biotechnology category.
View ArticleERYTECH announces the decision of USPTO to extend the additional exclusivity...
ERYTECH announces the decision of USPTO to extend the additional exclusivity period of its core process patent to almost 4 years
View Article